Leiters Press Release COVID-19
Leiters, a trusted FDA-registered 503B outsourcing provider of high-quality compounded sterile preparations, continues to closely monitor the evolving COVID-19 situation and the potential healthcare drug shortages.
You may also like
Long-Term Outcome of Children Treated with Neonatal Extracorporeal Membrane Oxygenation: Increasing Problems with Increasing Age
This review aims to provide an up-to-date overview of medical and neurodevelopmental outcomes in children who as neonates received treatment with extracorporeal membrane oxygenation (ECMO).
1 min read